153 related articles for article (PubMed ID: 2934019)
1. Cellular immunity in acne vulgaris during transfer factor treatment.
Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K
Ann Clin Res; 1985; 17(4):152-5. PubMed ID: 2934019
[TBL] [Abstract][Full Text] [Related]
2. The effect of transfer factor on cystic acne.
Gröhn P; Kuokkanen K; Krohn K
Acta Derm Venereol; 1978; 58(2):153-5. PubMed ID: 76396
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
4. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.
Leser PG; Margarido L; Belda W; Sartori SG; Hares WA; Freire CA; Fleury R; Montenegro MR; Leser W; Naspitz CK
Hansenol Int; 1980 Jun; 5(1):3-27. PubMed ID: 7042563
[TBL] [Abstract][Full Text] [Related]
5. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation in acne.
Lidén S; Göransson K; Odsell L
Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():47-52. PubMed ID: 6451126
[TBL] [Abstract][Full Text] [Related]
7. [Immunomodulating and therapeutic effects of the STAVA inj. preparation in acne vulgaris].
Jautová J; Jarcusková D; Ficová M; Dubivská M
Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):29-32. PubMed ID: 7757346
[TBL] [Abstract][Full Text] [Related]
8. Photopneumatic technology for the treatment of acne vulgaris.
Shamban AT; Enokibori M; Narurkar V; Wilson D
J Drugs Dermatol; 2008 Feb; 7(2):139-45. PubMed ID: 18335650
[TBL] [Abstract][Full Text] [Related]
9. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
Mobacken H; Hanson LA; Lindholm L; Ljunggren C
Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
[TBL] [Abstract][Full Text] [Related]
10. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of acne with a yeast preparation].
Weber G; Adamczyk A; Freytag S
Fortschr Med; 1989 Sep; 107(26):563-6. PubMed ID: 2530145
[TBL] [Abstract][Full Text] [Related]
12. Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study.
Hjorth N; Schmidt H; Thomsen K; Dela K
Acta Derm Venereol; 1984; 64(4):354-7. PubMed ID: 6209900
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of delayed type immune reactivity in patients with acne vulgaris.
Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K
Acta Derm Venereol; 1980; 60(4):333-6. PubMed ID: 6163280
[TBL] [Abstract][Full Text] [Related]
14. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
[TBL] [Abstract][Full Text] [Related]
15. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease.
Catanzaro A; Spitler LE; Campbell GD; Moser KM
Arch Intern Med; 1981 Mar; 141(4):533-7. PubMed ID: 7212899
[TBL] [Abstract][Full Text] [Related]
16. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
17. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of acne vulgaris. Double-blind study of a combination of 5% benzoyl peroxide/2% miconazole (Acnidazil) and tretinoin 0.05%].
Kavli G; Moseng D; Laastad O; Midelfart K; Nilsen JW; Falk ES; Stenvold SE; Volden G
Z Hautkr; 1984 Jul; 59(13):882-7. PubMed ID: 6235683
[TBL] [Abstract][Full Text] [Related]
19. [Parameters of cellular and humoral immunity in patients with severe acne].
Schmidt JB; Pinzker H; Eibl M
Z Hautkr; 1986 Oct; 61(19):1397-404. PubMed ID: 2431550
[TBL] [Abstract][Full Text] [Related]
20. Transfer factor as an approach to the treatment of immune deficiency disease.
Schulkind ML; Ayoub EM
Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
